ATI-22-107 is a positive cardiac inotropic agent which may affect myocyte calcium cycling and contractility. References: Jung AS, Quaile MP, Mills GD, Bednarik DP, Houser SR, Margulies KB. Pharmacological effects of ATI22-107 [2-(2-{2-[2-chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylami no}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxy lic acid dimethyl ester)], a novel dual pharmacophore, on myocyte calcium cycling and contractility. J Pharmacol Exp Ther. 2005 Feb;312(2):517-24. Epub 2004 Nov 18. PubMed PMID: 15550574.

纯度：≥98%

CAS：681816-57-9